IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. - Wikidata - wikimedia - TriplyDB

IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.

IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.

http://www.wikidata.org/entity/Q35369944

about

Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment Local tumour hyperthermia as immunotherapy for metastatic cancer.The gastrointestinal tumor microenvironment Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells Temperature matters! And why it should matter to tumor immunologists Understanding high endothelial venules: Lessons for cancer immunology Intraoperative intravital microscopy permits the study of human tumour vessels Peripheral tissue homing receptor control of naïve, effector, and memory CD8 T cell localization in lymphoid and non-lymphoid tissues.Optogenetic control of chemokine receptor signal and T-cell migration.The Thoc1 encoded ribonucleoprotein is required for myeloid progenitor cell homeostasis in the adult mouse Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy.Fever and the thermal regulation of immunity: the immune system feels the heat.Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transfer Mild Heat Treatment Primes Human CD34(+) Cord Blood Cells for Migration Toward SDF-1α and Enhances Engraftment in an NSG Mouse Model Shifts in temperature within the physiologic range modify strand-specific expression of select human microRNAs Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer.Elevated Serum Levels of Soluble TNF Receptors and Adhesion Molecules Are Associated with Diabetic Retinopathy in Patients with Type-1 Diabetes.Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints.IL-17 promoted the inhibition of medulloblastoma in mice by splenocyte injection.IL-6 Inhibition Reduces STAT3 Activation and Enhances the Antitumor Effect of Carboplatin.Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects.Interleukin-6 Induced "Acute" Phenotypic Microenvironment Promotes Th1 Anti-Tumor Immunity in Cryo-Thermal Therapy Revealed By Shotgun and Parallel Reaction Monitoring Proteomics.Leukocyte populations and IL-6 in the tumor microenvironment of an orthotopic colorectal cancer model Cancer prevention and therapy through the modulation of the tumor microenvironment.IL-17 promotes neutrophil entry into tumor-draining lymph nodes following induction of sterile inflammation.Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.Investigating the effect of tumor vascularization on magnetic targeting in vivo using retrospective design of experiment.Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes.The two faces of IL-6 in the tumor microenvironment.Antibody-modified T cells: CARs take the front seat for hematologic malignancies.Hitting a complex target: an update on interleukin-6 trans-signalling.Preconditioning thermal therapy: flipping the switch on IL-6 for anti-tumour immunity.Fever, hyperthermia and the heat shock response.Fever, immunity, and molecular adaptations.Central nervous system involvement in adult acute lymphoblastic leukemia: diagnostic tools, prophylaxis, and therapy.Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies.A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.

P2860

Q26799117-42864A3E-2109-464C-94A7-DFE7F6C18925 Q26823968-B7A5B70D-C772-453F-B59A-36F4953A428A Q26827391-6066B131-8125-4785-8BC5-94EE78497ED3 Q26852287-A46DA3E0-DA78-414C-B43E-58476A03E07C Q26853269-9F98118D-5574-481C-979E-FF8235799AB7 Q27005794-15F205D1-686A-4796-BD99-E58FB87C60FD Q27332331-8D0CBD04-0328-4519-9B3B-3A3195FCC48A Q30417609-28E0236E-E0DC-4DBA-BC8E-7459D5EC0443 Q30579021-060215AA-5E0A-4C41-A851-EF9C89D97DBD Q33618855-D2266C60-5909-4DA7-AB3A-BFECDB88899A Q33933665-EBAA1F4A-5E6F-44C8-8D59-9EE419C009D0 Q34476418-E1A8D3C8-0618-422C-9927-FE51B663EECC Q34919077-CB855A5F-08BB-4757-9B8B-933CFEDD10D8 Q35637523-45034492-4C51-470B-A981-F8B1ED497C39 Q35773262-E626F8BA-918C-49CA-86F6-6E10A4B643B5 Q35850047-F3AC5DE6-CE16-406A-B85C-ED5658D5D498 Q35908928-A146F39A-2698-4F09-AFBD-6A649E9EDB6E Q35962884-7738BB9C-6B64-448E-81C3-41168862047A Q36060263-978ED643-D8FD-4762-962B-71C49FA34E98 Q36160526-18D095A4-34F2-46D2-A66E-A7303E0901CA Q36383466-AAD00BDF-15C0-49BE-90AD-EA60994BAE7D Q36661347-1A2778CA-D120-473B-92D9-AC9F94F4C2B7 Q36674896-EC039AEF-E90D-48BB-BCCC-B0C57A9C3D4E Q36882938-89B528C4-C653-47A9-BE50-EEAE063535AE Q36949584-ABC6289D-676B-44BB-A0DB-383AE2D7550C Q37058267-17A0DE7B-D196-4D9E-954C-011ABCF7AC5A Q37228002-5510359A-E745-4A9A-B028-BA6AA47F808D Q37257207-F4CC00BD-FDB9-44C2-8B20-7B63D3DDAD0F Q37265298-2F654CE6-7DAD-44FF-82B5-5DC713C4DB4E Q37395218-A6E4EC22-8254-4272-AE7C-CCEFFBC8652D Q37544847-A64ABE92-6661-41D7-9E27-1868498E4FA4 Q37674796-675BF838-BAD6-47EF-8329-FB2E146A7A5D Q37723469-933CEAF3-5C8B-441F-AECD-13321238C42B Q37983123-2D809887-B4AC-4DB5-8259-70905B662902 Q38122205-D9E79D4D-223F-421B-8D0D-0DA72081043E Q38122209-42D4CB5D-8BA7-4623-9BF0-DCBE2A370296 Q38201381-AF972C85-F26A-42AA-924F-083A60B8FEBD Q38269513-94A02AE1-FF22-4F32-9BE4-784CB3FE9A80 Q38289029-4496E1D3-141E-422A-B26F-054E2575748E Q38373731-3C140919-D055-49FA-A483-FF3C80FF3244

P2860

IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells.

http://www.wikidata.org/entity/Q35369944

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

IL-6 trans-signaling licenses ...... fficking of cytotoxic T cells.

@ast

IL-6 trans-signaling licenses ...... fficking of cytotoxic T cells.

@en

type

label

IL-6 trans-signaling licenses ...... fficking of cytotoxic T cells.

@ast

IL-6 trans-signaling licenses ...... fficking of cytotoxic T cells.

@en

prefLabel

IL-6 trans-signaling licenses ...... fficking of cytotoxic T cells.

@ast

IL-6 trans-signaling licenses ...... fficking of cytotoxic T cells.

@en

P1433

Q35369944-E91ED4A6-0F3C-4DE7-8068-BBDFFA35DBB7

P1476

Q35369944-611ED04A-A0FA-47E9-856D-9C351C42994B

P2093

Q35369944-07647158-03C4-4EA7-8864-DB0D16869E32

Q35369944-29779276-FBDB-4A11-9DE7-D348A4F7676C

Q35369944-34E1F29F-4184-4B77-BA33-7E7F74198667

Q35369944-57066276-56B8-4116-8A7D-EB3814F32C1A

Q35369944-7186D2E7-3B71-4764-9F4F-FD8608743CE2

Q35369944-77621C1E-E1C4-4F46-A606-ECD22E2157F9

Q35369944-7E9C8464-35B7-42A5-8489-753C39F4FB78

Q35369944-830E9E0D-CDDA-402E-BEF3-A84D32033ECA

Q35369944-8385533E-E6AB-47A4-B0F1-020ECE8332EC

Q35369944-95B479E0-4164-462B-953D-E8A9B61A3D11

P2860

Q35369944-001311E5-34B7-4C48-821B-1B776CDC3EE8

Q35369944-0371CCAE-C9F2-4FFD-9A34-B99B06C873D8

Q35369944-062219CD-B9DB-4F43-B49F-B8E59F15776E

Q35369944-1366245C-DC37-4FBC-88FB-40C18DAF3600

Q35369944-15592E36-9415-4304-9119-DE6FB0354837

Q35369944-21C8A908-A941-4019-9DDF-8E3C242CC67B

Q35369944-260FBF77-CC5F-47F7-B2DC-56284490A1AA

Q35369944-29717ABA-0935-4169-85C0-581266CF40C2

Q35369944-2D8E85FA-C3D9-4B84-886D-49BB2C8E140C

Q35369944-31E2A7BE-1F2D-4103-A34C-DE4D60D313A8

P304

Q35369944-81066620-B225-46CE-8756-CA29AE028C99

P31

Q35369944-9A7E45DA-C819-486A-8326-61E95336D9F1

P356

Q35369944-F1180991-7DC3-445A-84E4-3CAD786718EA

P407

Q35369944-C08F051C-C4D4-48C1-B891-11868F010511

P433

Q35369944-56B5D680-37C3-4E1F-A2B0-3974E34EB6B0

P478

Q35369944-2F7A185D-84EA-492B-A23F-C8514D4D064B

P50

Q35369944-27D7BA02-FDA6-4E72-926F-7AC0A1348667

P577

Q35369944-8BF5CCD3-0AFF-440F-8639-63CAF84D66D9

P698

Q35369944-FB771B3E-FD71-418C-9420-4186B17B4DF9

P921

Q35369944-304C835F-1361-435E-AA79-2149E9F0EBB6

P932

Q35369944-181A7E6C-A172-45E9-9C65-A6D3AF3CB9AB

P356

P1433

Journal of Clinical Investigation

P1476

IL-6 trans-signaling licenses ...... fficking of cytotoxic T cells.

@en

P2093

Daniel T Fisher

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Repasky

http://www.w3.org/2001/XMLSchema#string

Emily L Weis

http://www.w3.org/2001/XMLSchema#string

Heinz Baumann

http://www.w3.org/2001/XMLSchema#string

Jason B Muhitch

http://www.w3.org/2001/XMLSchema#string

Jessica Passanese

http://www.w3.org/2001/XMLSchema#string

Joseph J Skitzki

http://www.w3.org/2001/XMLSchema#string

Lei Zhou

http://www.w3.org/2001/XMLSchema#string

Mark W Dewhirst

http://www.w3.org/2001/XMLSchema#string

Michelle M Appenheimer

http://www.w3.org/2001/XMLSchema#string

P2860

Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

Cancer regression in patients after transfer of genetically engineered lymphocytes

Tumor self-seeding by circulating cancer cells

Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer

Immunity, Inflammation, and Cancer

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses

Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice

P304

3846-3859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI44952

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Stefan Rose-John

P577

2011-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21926464

http://www.w3.org/2001/XMLSchema#string

P921

P932

3195455

http://www.w3.org/2001/XMLSchema#string